Stock Market News
Smith & Nephew profit rises as knee implant sales increase
Smith & Nephew reported a 17% rise in annual profit as the medical products company sold more knee implants and increased sales in emerging markets.
Operating profit for the year to the end of December increased to $934m (£672m) from $801m as revenue rose 2% to $4.8bn. Trading profit, which strips out non-trading items, rose to $1.05bn from $1.02bn.
Smith & Nephew makes replacement joints, wound treatments and products that help repair broken bones. Annual sales of knee implants rose 5% on an underlying basis to $984m.
Revenue rose 12% in emerging markets to $781m. In the US, which makes up almost half Smith & Nephew's business, revenue rose 2% to $2.3bn and revenue was flat in Europe and other established markets.
Olivier Bohuon, Smith & Nephew's chief executive, said: "We delivered on our promises to improve the top and bottom line in 2017. Our knee implants franchise delivered a standout performance and we returned to double-digit growth in the emerging markets. Our healthy balance sheet, good cash generation and increased dividend demonstrate the robust foundations underpinning our business."
Bohuon said he expected 2018 to be another year of improvement with underlying revenue rising by 3-4% and profit margins improving. Smith & Nephew increased the annual dividend by 14% to 35 cents a share.
Operating profit for the year to the end of December increased to $934m (£672m) from $801m as revenue rose 2% to $4.8bn. Trading profit, which strips out non-trading items, rose to $1.05bn from $1.02bn.
Smith & Nephew makes replacement joints, wound treatments and products that help repair broken bones. Annual sales of knee implants rose 5% on an underlying basis to $984m.
Revenue rose 12% in emerging markets to $781m. In the US, which makes up almost half Smith & Nephew's business, revenue rose 2% to $2.3bn and revenue was flat in Europe and other established markets.
Olivier Bohuon, Smith & Nephew's chief executive, said: "We delivered on our promises to improve the top and bottom line in 2017. Our knee implants franchise delivered a standout performance and we returned to double-digit growth in the emerging markets. Our healthy balance sheet, good cash generation and increased dividend demonstrate the robust foundations underpinning our business."
Bohuon said he expected 2018 to be another year of improvement with underlying revenue rising by 3-4% and profit margins improving. Smith & Nephew increased the annual dividend by 14% to 35 cents a share.
Related share prices |
---|
Smith & Nephew (SN.) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price